Industry and Commercialisation Committee

We recognise the importance of industry as a key partner in the translational pipeline. This Committee advises and identifies key areas for industry engagement and commercialisation opportunities in the cardiovascular sector.

Professor Kerry-Anne Rye, Chair

Emerging Leaders Committee

Our Emerging Leaders Committee (ELC) was established to provide Early- and Mid-Career Researchers (EMCRs) with  greater experience and opportunity in the cardiovascular sector. 

They advise and recommend priorities for support, engagement and development of ACvA’s EMCRs through a variety of targeted capacity building programs.

NiamhChapman
Chair - Dr Niamh Chapman
Dr Harry Carpenter
Dr Lauren Blekkenhorst
Dr Sharon Kramer
Dr Katrina Colafella
Dr Julee McDonagh
Dr Shajedur Rahmon Shawon
Dr Jing Tian
Dr Emma Solly
Ingrid Stacey
Dr Richard Tan

Scientific Advisory Committee

The SAC is a standing sub-committee of the ACvA, providing advice to the ACvA Board on the development of programs and initiatives to achieve the overall vision of building a vibrant sustainable research ecosystem serving health and the economy.

 

Our SAC members have a strong research and leadership track record and are committed to the vision and goals of the ACvA. They represent a range of disciplines and have skills and expertise.

Professor Dominique Cadilhac
Professor Jon Kalman
Professor Lee Nedkoff
Professor Julie Redfern
Professor Nathan Palpant
Professor Michael Stowasser
Professor Rebecca Ritchie
A/Prof Jelena Rnjak-Kovacina
Professor Jamie Vandenberg